Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8221309 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
Tumor height and mrEMVI status are more important than baseline size and stage of the tumor as predictors of response to CRT. Both MRI- and pathologic-defined responders have significantly improved survival. “Good response” to CRT in locally advanced rectal cancer with ypT0-2 carries significantly better 3-year overall survival and disease-free survival. Use of induction chemotherapy for improving mrEMVI status and knowledge of MRI predictive factors could be taken into account in the pursuit of individualized neoadjuvant treatments for patients with rectal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Stanley K.T. MBBS, FRCR, Diana MD, FRCR, Ian MD, MRCP, Gina MD, FRCR,